Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

OBJECTIVE: To systematically evaluate the efficacy and safety of alectinib versus crizotinib in the treatment of anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer. METHODS: Studies about the efficacy of alectinib versus crizotinib in the treatment of ALK-positive non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hao, Jin, Longyu, Zhang, Zhang, Jiang, Zhibin, Malik, Zeeshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206528/
https://www.ncbi.nlm.nih.gov/pubmed/34150615
http://dx.doi.org/10.3389/fonc.2021.646526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206528/
https://www.ncbi.nlm.nih.gov/pubmed/34150615
http://dx.doi.org/10.3389/fonc.2021.646526

Ejemplares similares